Patient Registry Software Market by Function (Health Information Exchange, Medical Research & Clinical Studies, Patient Care Management), Type (Disease Registries, Health Service Registries, Product Registries), Database Type, Software, Pricing Model, End

Patient Registry Software Market by Function (Health Information Exchange, Medical Research & Clinical Studies, Patient Care Management), Type (Disease Registries, Health Service Registries, Product Registries), Database Type, Software, Pricing Model, End-User - Global Forecast 2024-2030


The Patient Registry Software Market size was estimated at USD 1.58 billion in 2023 and expected to reach USD 1.83 billion in 2024, at a CAGR 15.89% to reach USD 4.44 billion by 2030.

The patient registry software is a specialized database used extensively within the healthcare sector to gather, organize, and store patient data regarding different medical conditions, treatments, or specialties. The primary purpose of the patient registry software is to streamline patient management, monitor treatment outcomes, support clinical studies and research, and efficiently manage large volumes of patient data, facilitating improved patient care, enhancing research capabilities, and aiding in public health initiatives. The patient registry software supports healthcare providers in tracking the efficacy of treatments, identifying potential areas for intervention, and optimizing healthcare delivery for better patient outcomes. The primary drivers of the patient registry software market include the increasing prevalence of chronic diseases, the need for efficient disease management strategies, the rising emphasis on value-based care, and the rising adoption of digital health technologies. However, the sensitivity of patient data necessitates stringent data protection measures, which are challenging for healthcare providers to implement. The government initiatives promoting health information technology for electronic health records (EHR) integration and patient management are providing lucrative opportunities to expand the patient registry software market.

Regional Insights

The patient registry software market is experiencing growth in the Americas, primarily driven by advanced technology, robust healthcare infrastructure, and favorable regulatory policies, with the U.S heavily investing in healthcare IT and focusing on R&D. The Americas region is experiencing an increased demand for cloud-based solutions and integrated registries to enhance patient outcomes and support research, driven by regulations encouraging electronic health records (EHRs) and software for disease monitoring and population health management. The patient registry software market in Asia-Pacific is witnessing expansion, driven by the increasing burden of chronic diseases, rising healthcare spending, and growing awareness of the benefits of patient registries, with China, India, and Japan making significant advances in health informatics and digital health. However, initiatives to improve healthcare infrastructure and digital health adoption are expected to boost the market growth in the Asia-Pacific region. The EMEA region presents a mixed scenario, with Europe having strict data protection laws ensuring high data security and privacy standards. The need for this software in Europe is focused on managing chronic diseases and healthcare planning, while the Middle East exhibits gradual growth through government efforts to upgrade healthcare systems and emphasize high-quality patient care. The patient registry software is increasingly being adopted in Africa due to rising healthcare investments and a focus on addressing chronic conditions.

Market Insights
  • Market Dynamics

    The market dynamics represent an ever-changing landscape of the Patient Registry Software Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
    • Market Drivers
      • Increasing prevalence of chronic diseases and the urgent need to manage the growing patient pool
      • Government initiatives supporting the digitalization of healthcare infrastructure
      • Expansion of clinical trials and clinical research studies worldwide
      • Market Restraints
        • Difficulties associated with integration of patient registry software with healthcare framework
        • Market Opportunities
          • Advancements to improve the reliability, performance, and functional features of patient registry software
          • Ongoing regulatory approvals for patient registry software
          • Market Challenges
            • Concerns related to data privacy and security
            • Market Segmentation Analysis
              • Function: Significant utility of patient registry software for health information exchange and patient care management
              • Type: Growing need for health service registries to cater to the broader requirements of healthcare systems
              • Database Type: Increasing preference toward adopting commercial databases within the patient registry software sector
              • Software: Widening use of integrated software for seamless integration within larger healthcare ecosystems
              • Pricing Model: Rising use of the subscription model owing to its ability to provide ongoing updates, support, and scalability
              • End-User: Government entities with third party administrators (TPAs) are pivotal in advancing the effectiveness and personalization of patient care services
              • Market Disruption Analysis
              • Porter’s Five Forces Analysis
              • Value Chain & Critical Path Analysis
              • Pricing Analysis
              • Technology Analysis
              • Patent Analysis
              • Trade Analysis
              • Regulatory Framework Analysis
              FPNV Positioning Matrix

              The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Patient Registry Software Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

              Market Share Analysis

              The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Patient Registry Software Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

              Recent Developments
              • HealthVerity FLOW 1.1 Upgraded to Better Contextualize the Patient Journey and Offer Novel Next-Best Actions Across the Life Sciences Industry

                HealthVerity, an enterprise data and AI specialist, introduced the upgraded HealthVerity Flow 1.1, marking a significant advancement in contextualizing the patient journey across the life sciences industry. This enhanced platform offers unparalleled insights for next-best-action decisions, leveraging the latest in privacy-secured technologies. HealthVerity FLOW 1.1 empowers stakeholders with actionable intelligence, fostering improved patient outcomes through tailored therapeutic strategies.

                Milliman Launches Research Tool Built on CMS Qualified Entity Data

                Milliman, Inc. unveiled an innovative interactive research dashboard, offering a detailed analysis of healthcare provider performance metrics along with social determinants of health (SDoH) data. The Milliman Qualified Entity Reporting Dashboard revolutionizes access to comprehensive healthcare data by allowing users to explore information down to the ZIP code tabulation area (ZCTA) level, facilitating a granular understanding of provider performance and SDoH factors. The dashboard has been developed as part of Milliman's involvement in the Centers for Medicare and Medicaid Services (CMS) Qualified Entity Program, leveraging the extensive Medicare data available to generate insights previously unavailable to the public, payers, providers, and researchers alike.

                ONCO, Inc. Announces Strategic Partnership with Oncora Medical to Launch Data-Driven Software Automation to Enhance Patient Care and Oncology Data Management

                ONCO Inc. collaborated with Oncora Medical to fuse ONCO's comprehensive suite of data collection and utilization tools with Oncora's cutting-edge patient care and analytics software, developed in collaboration with MD Anderson Cancer Center, to forge a unified platform. This platform indicates a new era in cancer treatment by facilitating automated cancer registry abstraction alongside personalized patient care, leveraging data automation and machine learning.
              Strategy Analysis & Recommendation

              The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Patient Registry Software Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

              Key Company Profiles

              The report delves into recent significant developments in the Patient Registry Software Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, ArborMetrix, Inc., Cedaron Medical, Inc., Common Management Solutions, S.L., Deutsche Telekom AG, Elekta AB, Epic Systems Corporation, EVADO Pty. Ltd., EvidentIQ Group GmbH, Fivos, Inc., Global Vision Technologies, Inc., Google LLC by Alphabet Inc., Health Catalyst, Inc., Healthmonix, Hewlett Packard Enterprise Development LP, Ifa systems AG, ImageTrend, Inc., Intelerad Medical Systems Incorporated, International Business Machines Corporation, IQVIA Holdings Inc., McKesson Corporation, Microsoft Corporation, Milliman, Inc., MRO Corporation, OpenText Corporation, Optum, Inc., Oracle Corporation, Ordinal Data, Inc., RAYLYTIC GmbH, Seqster PDM, Inc., Syneos Health, Inc., Veradigm LLC, Vitro Software Holdings DAC, and WIRB-Copernicus Group.

              Market Segmentation & Coverage

              This research report categorizes the Patient Registry Software Market to forecast the revenues and analyze trends in each of the following sub-markets:
              • Function
                • Health Information Exchange
                • Medical Research & Clinical Studies
                • Patient Care Management
                • Point-of-Care
                • Population Health Management
                • Product Outcome Evaluation
                • Type
                  • Disease Registries
                    • Asthma Registries
                    • Cancer Registries
                    • Cardiovascular Registries
                    • Chronic Kidney Disease Registries
                    • Diabetes Registries
                    • Orthopedic Registries
                    • Rare Disease Registries
                    • Health Service Registries
                    • Product Registries
                      • Drug Registries
                      • Medical Device Registries
                      • Database Type
                        • Commercial Databases
                        • Public Databases
                        • Software
                          • Integrated Software
                          • Standalone Software
                          • Pricing Model
                            • Ownership Model
                            • Subscription Model
                            • End-User
                              • Academic & Research Institutes
                              • Government Organizations
                              • Healthcare Patients
                              • Healthcare Payers
                              • Healthcare Providers
                              • Pharmaceutical & Biotechnology Companies
                              • Region
                                • Americas
                                  • Argentina
                                  • Brazil
                                  • Canada
                                  • Mexico
                                  • United States
                                    • California
                                    • Florida
                                    • Illinois
                                    • New York
                                    • Ohio
                                    • Pennsylvania
                                    • Texas
                                    • Asia-Pacific
                                      • Australia
                                      • China
                                      • India
                                      • Indonesia
                                      • Japan
                                      • Malaysia
                                      • Philippines
                                      • Singapore
                                      • South Korea
                                      • Taiwan
                                      • Thailand
                                      • Vietnam
                                      • Europe, Middle East & Africa
                                        • Denmark
                                        • Egypt
                                        • Finland
                                        • France
                                        • Germany
                                        • Israel
                                        • Italy
                                        • Netherlands
                                        • Nigeria
                                        • Norway
                                        • Poland
                                        • Qatar
                                        • Russia
                                        • Saudi Arabia
                                        • South Africa
                                        • Spain
                                        • Sweden
                                        • Switzerland
                                        • Turkey
                                        • United Arab Emirates
                                        • United Kingdom


                                        Please Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of chronic diseases and the urgent need to manage the growing patient pool
5.1.1.2. Government initiatives supporting the digitalization of healthcare infrastructure
5.1.1.3. Expansion of clinical trials and clinical research studies worldwide
5.1.2. Restraints
5.1.2.1. Difficulties associated with integration of patient registry software with healthcare framework
5.1.3. Opportunities
5.1.3.1. Advancements to improve the reliability, performance, and functional features of patient registry software
5.1.3.2. Ongoing regulatory approvals for patient registry software
5.1.4. Challenges
5.1.4.1. Concerns related to data privacy and security
5.2. Market Segmentation Analysis
5.2.1. Function: Significant utility of patient registry software for health information exchange and patient care management
5.2.2. Type: Growing need for health service registries to cater to the broader requirements of healthcare systems
5.2.3. Database Type: Increasing preference toward adopting commercial databases within the patient registry software sector
5.2.4. Software: Widening use of integrated software for seamless integration within larger healthcare ecosystems
5.2.5. Pricing Model: Rising use of the subscription model owing to its ability to provide ongoing updates, support, and scalability
5.2.6. End-User: Government entities with third party administrators (TPAs) are pivotal in advancing the effectiveness and personalization of patient care services
5.3. Market Trend Analysis
5.3.1. Modernize healthcare infrastructure and presence of established market players supports advancements in data security across Americas
5.3.2. Significant government support for digitalization of healthcare IT infrastructure and proliferation of eHealth and mobile applications across the APAC region
5.3.3. Reinforcing stringent regulation for patient data privacy, shift toward patient-centric healthcare solutions, and strategic collaborations between players to provide digital healthcare services in EMEA
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Patient Registry Software Market, by Function
6.1. Introduction
6.2. Health Information Exchange
6.3. Medical Research & Clinical Studies
6.4. Patient Care Management
6.5. Point-of-Care
6.6. Population Health Management
6.7. Product Outcome Evaluation
7. Patient Registry Software Market, by Type
7.1. Introduction
7.2. Disease Registries
7.3. Health Service Registries
7.4. Product Registries
8. Patient Registry Software Market, by Database Type
8.1. Introduction
8.2. Commercial Databases
8.3. Public Databases
9. Patient Registry Software Market, by Software
9.1. Introduction
9.2. Integrated Software
9.3. Standalone Software
10. Patient Registry Software Market, by Pricing Model
10.1. Introduction
10.2. Ownership Model
10.3. Subscription Model
11. Patient Registry Software Market, by End-User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Government Organizations
11.4. Healthcare Patients
11.5. Healthcare Payers
11.6. Healthcare Providers
11.7. Pharmaceutical & Biotechnology Companies
12. Americas Patient Registry Software Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Patient Registry Software Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Patient Registry Software Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. HealthVerity FLOW 1.1 Upgraded to Better Contextualize the Patient Journey and Offer Novel Next-Best Actions Across the Life Sciences Industry
15.3.2. Milliman Launches Research Tool Built on CMS Qualified Entity Data
15.3.3. ONCO, Inc. Announces Strategic Partnership with Oncora Medical to Launch Data-Driven Software Automation to Enhance Patient Care and Oncology Data Management
15.3.4. Alira Health and FORWARD Launch Enhanced Lupus Patient Registry, Accelerating Solutions for Patients
15.3.5. Health Catalyst Acquires ERS, Bolsters Tech-Enabled Managed Services Offering with Data Abstraction and Oncology Registry Management Capabilities
15.3.6. PHC Group Completes Acquisition of FUJIFILM Healthcare Systems’ Electronic Medical Record and Medical-Receipt Systems Business
15.3.7. Medicare Rolls Out Alzheimer Patient Registry After FDA Approval
15.3.8. Verantos Launches Pragmatic Registry Product and New Registry in Severe Asthma
15.3.9. The SPHERES Registry for NMOSD Patients Launches Precision Medicine Program
15.3.10. Vital Secures USD 24.7 Million in Series B Funding to Advance its Artificial Intelligence-Driven Software for Patients, Hospitals and Health Systems
15.3.11. Nuance and Microsoft Announce the First Fully AI-Automated Clinical Documentation Application for Healthcare
15.3.12. Eka Care, a Startup Helping Digitize Health Records of Indian Patients, Raises USD 15 million
16. Competitive Portfolio
16.1. Key Company Profiles
16.2. Key Product Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings